Trump Order Cuts Childhood Vaccines to 11, Shifts 7 to Shared Decision

President Donald Trump has signed an executive order recognizing 11 core childhood immunizations as "gold standard" protection, removing seven diseases from the 18 previously recommended by the Centers for Disease Control and Prevention (CDC) in 2024 [2]. The order also directs the Justice Department to litigate against state vaccination laws deemed inconsistent with parental authority, religious freedom, disability accommodations, or equal protection, potentially reshaping school immunization requirements [2].

Executive Order Details and Rationale

The executive order, signed by President Trump, narrows universal childhood immunization recommendations to 11 diseases, while seven previously routine vaccines will now fall under "shared clinical decision-making" between parents and doctors [2]. The order also calls for the combined measles, mumps, and rubella (MMR) shot to be split into three separate injections given at separate visits [2]. States with school vaccine requirements are "advised to consider" the new recommendations and update their laws, though the order does not mandate compliance [2].

The White House cited a January 2026 scientific assessment by the Department of Health and Human Services (HHS) that compared U.S. childhood immunization recommendations with those of other nations [2]. This assessment found that the U.S. recommends more childhood vaccines than any peer nation, including more than twice as many doses as some European countries [2]. It noted that in 1980, children following the CDC schedule received 23 vaccine doses against seven diseases, which had grown to at least 84 doses covering 17 diseases by 2024, plus an RSV monoclonal antibody immunization, totaling 18 diseases [2]. The assessment also indicated that most peer nations maintain high vaccination rates through public trust and education rather than mandates, and that the U.S. is among a minority of peer nations mandating childhood vaccines for school entry [2]. President Trump also cited a growing number of U.S. autism diagnoses, suggesting a link to vaccines [2].

Medical Community Response and Feasibility Concerns

Physicians and medical groups have rejected the administration's rationale, stating that no new science justifies the changes [2]. Dr. Andrew Racine, president of the American Academy of Pediatrics, called the order "not only disheartening but dangerous," emphasizing that the existing U.S. schedule is based on decades of evidence [2]. Racine noted that measles cases in the U.S. have reached a 35-year high and reiterated that numerous studies have found no link between vaccines and autism [2]. He stated that the order's purpose is to "sow confusion" and warned of risks from delaying or skipping shots [2].

The order's call to split the MMR shot into three single-disease injections has drawn skepticism [2]. Merck, the manufacturer, states there is no published scientific evidence supporting any benefit to splitting the combined vaccine, and that using individual components would increase injections and could lead to delayed or missed immunizations [2]. Dr. Elizabeth Mack, a pediatric critical care physician, noted that no licensed single-antigen measles, mumps, or rubella vaccines are currently available in the U.S., making the recommendation unfeasible as written [2]. She also questioned whether insurers would reimburse for the additional visits required [2].

What to watch

• State-level responses: Monitor how states with existing school vaccine mandates react to the executive order's advice to reconsider their laws [2].
• DOJ litigation: Watch for any legal challenges initiated by the Justice Department against state vaccination laws deemed inconsistent with the order's principles [2].
• Vaccine availability: Observe if any single-antigen measles, mumps, or rubella vaccines become available in the U.S., which would be necessary to implement the order's recommendation to split the MMR shot [2].

The executive order marks a significant shift in federal guidance on childhood immunizations, potentially creating a conflict between federal recommendations and established medical consensus, with implications for public health and state-level vaccine policies.